Washington, DC 20006-5349
HELPLINE
Three mesothelioma patients shared their experiences with cancer-related cognitive impairment — also known as “chemo brain” — with Dr. Tracy Vannorsdall, a neuropsychologist at the…
For MesoTV, we brought back a valuable conversation about complementary vs alternative therapies from a previous conference on malignant mesothelioma in New York City. In…
In this video, Jane Churpek, MD, MS, discusses inherited genetics and mesothelioma, in particular as they relate to the BAP1 gene and the BRCA2. Specifically, she covers how…
Elliot Wakeam, MD, discussed mesothelioma treatment at the University of Michigan. Dr. Wakeam is a thoracic and lung transplant surgeon and assistant professor who uses…
Adnan Jaigirdar, MD, FACS, provides an overview of the U.S. Food and Drug Administration (FDA) expanded access program (compassionate use) for investigative therapies for mesothelioma patients. Dr. Jaigirdar is…
Five mesothelioma patients — Heather Von St. James, Rich Mosca, Liam Bradley, John Panza and Sara Babin — gathered for a community panel discussion on…
Charles Hesdorffer, MD discussed the immune system and its response to viral infections such as COVID-19, especially as it relates to mesothelioma patients. Dr. Hesdorffer…
Michael Becich, MD, PhD explains the background and purpose of the National Mesothelioma Virtual Tissue Bank (NMVB) — the only national tissue and data repository…
Susan Gillette, LAc led a tutorial on a technique called “tapping” with Katie Jamieson and Heather Von St James, co-chairs of our Community Advisory Board.…
Liz Darlison, head of services at Mesothelioma UK, spoke with Mary Hesdorffer, NP, about mesothelioma treatment in the United Kingdom during COVID-19 and in general. Liz is a…
